PO.BCS01.10 · 生物信息与计算
胃肿瘤切片的三维空间多组学揭示超越二维分析的隐藏特征
Three-dimensional spatial multi-omics of gastric tumor sections reveal hidden features beyond 2D analyses
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
单切片空间组学常常遗漏微观解剖学背景,且对切片变异性敏感。近期的三维重建研究凸显了肿瘤微环境内部存在的显著异质性,掩盖了真实的生物学。新兴平台(如Singular Genomics G4X)能够在同一载玻片上以亚细胞分辨率进行原位RNA/蛋白读取,并配合荧光H&E,从而创建序列化的空间多组学。这项工作使我们能够在亚细胞水平上以x-y-z坐标绘制转录本丰度图谱,在厚组织上整合H&E、转录本与蛋白,实现真正的三维空间多模态肿瘤建模。我们使用G4X系统对连续FFPE切片进行分析,联合定量每张切片的靶向RNA与蛋白。跨切片比较细胞类型、邻域富集矩阵与基因集富集,以衡量切片间的不一致性。随后,我们将连续切片配准到共同的三维框架中,重建了体积图谱,并识别了耗竭T细胞程序的三维热点。为直接可视化这些模式是否反映了真实的三维结构,我们从相同的连续切片获取了无标记三维全息断层成像,将其与相应的连续G4X数据在共享三维空间中对齐,应用基于AI的单细胞分割,并将由G4X RNA与蛋白表达定义的细胞类型映射回其x-y-z坐标。连续的二维切片显示出不一致的细胞类型组成与邻域富集,表明即使在单个肿瘤块内也存在强烈的变异性。相比之下,三维重建揭示了一个连贯的耗竭T细胞区域,而该区域在任何单张切片中都未能达到统计学显著性。全息断层成像证实了T细胞、细胞外基质与肿瘤细胞在深度方向上存在致密、连续的界面,支持了真实的生物学连续性,并在三维中展示了转录本与蛋白的亚细胞定位。我们的三维空间多组学方法表明,单切片分析可能会遗漏具有临床意义的免疫生态位,而整合的三维RNA-蛋白-全息断层成像分析则能够恢复隐藏的信号。通过在薄组织与厚组织中以亚细胞x-y-z坐标绘制并结合转录本、蛋白与三维全息断层成像,我们提供了一套实用的体积肿瘤-免疫分析工作流程,可加速胃癌的生物标志物发现与治疗靶向,并可推广至其他癌症类型。"生成式AI仅用于编辑本摘要的语言。作者对研究概念、数据解释与结论负责,并已批准最终版本。"
查看英文原文 English abstract
Single-section spatial-omics frequently misses microanatomical context and is sensitive to sectioning variability. Recent 3D reconstruction studies highlight substantial heterogeneity within the tumor microenvironment obscuring true biology. Emerging platforms (e.g. Singular Genomics G4X) enable in-situ RNA/protein readouts at subcellular resolution on the same slide with fluorescent H&E, creating serialized spatial multi-omics. This work allows us to map transcript abundance at the subcellular level with x-y-z coordinates, integrating H&E, transcripts, and proteins on the thick tissues, enabling true 3D spatial multimodal tumor modeling.We profiled serial FFPE sections using the G4X system to jointly quantify targeted RNAs and proteins per slice. Across slices, we compared cell types, neighborhood enrichment matrices, and gene-set enrichment to measure inter-slice inconsistency. We then registered the serial sections into a common 3D frame, reconstructed a volumetric atlas, and identified 3D hotspots for exhausted T-cell programs. To directly visualize whether these patterns reflected true 3D structure, we acquired label-free 3D holotomography from the same serial sections, aligned them with the corresponding serial G4X data in a shared 3D space, applied AI-based single-cell segmentation, and mapped cell types defined by G4X RNA and protein expression back to their x-y-z coordinates.Serial 2D slices showed discordant cell-type compositions and neighborhood enrichments, indicating strong variability even within a single tumor block. In contrast, 3D reconstruction revealed a coherent exhausted T-cell domain that failed to reach statistical significance in any individual slice. Holotomography confirmed dense, continuous interfaces among T cells, extracellular matrix, and tumor cells across depth, supporting true biological continuity and demonstrating subcellular localization of transcripts and proteins in 3D.Our 3D spatial multi-omic approach shows that single-section analyses may miss clinically relevant immune niches, whereas integrated 3D RNA-protein-holotomography profiling recovers hidden signals. By mapping and combining the transcripts with proteins and the 3D holotomography at subcellular x-y-z coordinates in thin and thick tissues, we provide a practical workflow for volumetric tumor-immune profiling that can accelerate biomarker discovery and therapeutic targeting in gastric cancer and can be generalized to other cancer types."Generative AI was used only to edit this abstract's language. The authors are responsible for the study concept, data interpretation, and conclusions, and have approved the final version."
利益披露 Disclosure
I. Jang, None..
S. Im, None..
M. Kim, None..
S. Chung, None..
M. Lee, None..
S. Lee, None..
J. Jang, None.
T. Hwang,
Kure.AI Other, co-founder of Kure.ai therapeutics and Kure.s and has received consulting fees from IQVIA; these affiliations and financial compensations are independent of the research described in this paper. The companies Kure.ai therapeutics and Kure.s had no influence on the study design, data collection and analysis, preparation of the paper or decision to publish.